Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

46.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.7K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

107
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
107
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

129
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
129
Retroviruses02:33

Retroviruses

12.7K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural and Mechanistic Basis of F227C-Mediated Hypersusceptibility to Islatravir in HIV-1 Reverse Transcriptase.

bioRxiv : the preprint server for biology·2026
Same author

Unraveling the Mechanism of HIV-1 Hypersusceptibility to Tenofovir Imparted by Islatravir Resistance Mutations.

bioRxiv : the preprint server for biology·2026
Same author

Cell-based platforms for antiviral screening against hepatitis B virus: advantages, limitations, and future perspectives.

Antiviral research·2026
Same author

Fpr1p mediates the synergistic effect of rapamycin or tacrolimus with caspofungin in <i>Clavispora lusitaniae in vitro</i>.

JAC-antimicrobial resistance·2026
Same author

Preclinical evaluation of a bivalent conjugate vaccine against <i>Salmonella</i> Typhi and Paratyphi A.

Frontiers in immunology·2026
Same author

Stereoselective synthesis of 1'-α-cyano carbocyclic pyrimidine nucleoside analogs <i>via</i> a chelation-controlled 1'-α-hydroxymethylation strategy.

Organic & biomolecular chemistry·2026

Related Experiment Video

Updated: Sep 5, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

HIV nucleoside reverse transcriptase inhibitors.

Franck Amblard1, Dharmeshkumar Patel1, Eleftherios Michailidis1

  • 1Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, and Children's Healthcare of Atlanta, 1760 Haygood Drive, Atlanta, GA, 30322, USA.

European Journal of Medicinal Chemistry
|July 6, 2022
PubMed
Summary
This summary is machine-generated.

HIV remains a global challenge, but highly active antiretroviral therapy (HAART) manages the infection. This review covers nucleoside reverse transcriptase inhibitors (NRTIs), their mechanisms, resistance, and current use in long-acting regimens.

Keywords:
HIVInhibitorsNucleosideProdrugRTReverse transcriptase

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.9K
Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells
13:07

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells

Published on: January 30, 2019

9.4K

Related Experiment Videos

Last Updated: Sep 5, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

17.9K
Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells
13:07

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells

Published on: January 30, 2019

9.4K

Area of Science:

  • Virology
  • Infectious Diseases
  • Pharmacology

Background:

  • HIV/AIDS remains a significant global health burden over 40 years into the pandemic.
  • Highly active antiretroviral therapy (HAART) is crucial for managing and suppressing HIV infection.
  • Combinations of antiretroviral drugs, particularly those targeting HIV reverse transcriptase (RT), form the basis of current HIV treatment.

Purpose of the Study:

  • To provide a comprehensive review of nucleoside reverse transcriptase inhibitors (NRTIs) in HIV treatment.
  • To detail the history, mechanisms of action, and resistance patterns of various NRTI classes.
  • To discuss the current clinical applications of NRTIs, including emerging long-acting regimens.

Main Methods:

  • Literature review of scientific publications on HIV reverse transcriptase inhibitors.
  • Analysis of drug mechanisms, resistance pathways, and clinical trial data.
  • Synthesis of information on NRTI history, classification, and therapeutic use.

Main Results:

  • NRTIs are a cornerstone of HAART, acting through various mechanisms like chain termination and translocation inhibition.
  • Different classes of NRTIs, including chain terminators, delayed chain terminators, NRTTIs, and NcRTIs, have distinct properties.
  • Understanding NRTI resistance is critical for effective treatment strategies.
  • Long-acting NRTI regimens represent a significant advancement in HIV management.

Conclusions:

  • NRTIs are indispensable in managing HIV infection, with ongoing research into novel formulations and resistance mitigation.
  • The evolution of NRTIs has significantly improved patient outcomes and quality of life.
  • Future directions include optimizing long-acting NRTI therapies for sustained viral suppression and improved adherence.